The application of a targeted metabolomics approach to serum samples collected at baseline, prior to the appearance of dementia symptoms, enabled us to elucidate the intertwined modulation of the fatty acid-related metabolome by ApoE-ε4 and sex at very early stages of CD, and thereby complement previous studies conducted in AD populations [10–12]. This evidence concerns the gene APOE and Alzheimer disease.